Jcog9912
WebDuring our analysis of ORR, all included studies were pooled to gather statistics, three of which had been designed as comparative trials between apatinib and tegafur gimeracil oteracil potassium capsule (S-1) which had already been recommended for standard chemotherapy in People’s Republic of China according to JCOG9912. 23 Owing to the … Web1 gen 2016 · JCOG9912 did not prespecify subsequent treatment, including second-line or third-line chemotherapy regimens. As a result, physician management choices, including those related to subsequent treatment, might have contributed significantly to the heterogeneity among participating hospitals, including the large gap in estimated OS …
Jcog9912
Did you know?
Web胃癌 JCOG9912; 胃癌 JCOG9912. Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study. Boku N, Yamamoto S, Fukuda H, et al. Lancet Oncol. 2009;10:1063-9 . WebImpact of excision repair cross-complementing gene 1 (ERCC1) on the outcomes of patients with advanced gastric cancer: Correlative study in Japan Clinical Oncology Group Trial …
Web26 ott 2013 · Two randomized phase III trials of first-line chemotherapy for advanced gastric cancer (JCOG9205 and JCOG9912) conducted by the Japan Clinical Oncology Group … Web1 ott 2013 · Patients and methods. Endoscopic biopsy specimens from primary lesions were collected in 445 of 704 randomized patients in JCOG9912. We measured the mRNA …
http://down.aisoutu.com/a/666450 Web8 ott 2009 · Yamada Y, Yamamoto S, Ohtsu A, et al. Impact of dihydropyrimidine dehydrogenase status of biopsy specimens on efficacy of irinotecan plus cisplatin, S-1, or 5-FU as first-line treatment of advanced gastric cancer patients in JCOG9912. 2009 ASCO annual meeting; Orlando, FL, USA; May 29–June 2, 2009. Abstract 4535.
WebTable II . The JCOG9912 and JCOG0106 trials were conducted during the period of our analysis and 30% of the patients at TCC were also enrolled in those trials. The median survival time was 11.7 months and the median follow-up period of the survivors was 17.5 months (range, 1.4-43 months). Complications. As determined by our diagnostic criteria, the
WebBackground: Laparoscopy-assisted distal gastrectomy (LADG) is increasingly being used as an alternative to open distal gastrectomy (ODG) for gastric cancer treatment. … dhis 2 softwareWeb20 giu 2007 · LBA4513 Backgrounds: We conducted a 3-arm phase III study to investigate superiority of CP and non-inferiority of S-1 to 5-FU for advanced gastric cancer in the primary endpoint of overall survival (OS) and secondary endpoints of response rate (RR), time to treatment failure (TTF), non-hospitalized survival (NHS) and toxicities. Methods: … cigna open access hsa planWeb腹腔镜辅助全胃切除与近端胃切除术治疗胃上部癌的围手术期临床疗效对比研究. 2024-09-03 胡子龙 张凯 胡时栋 邢晓伟 何长征 李宇轩 王玉锋 杜晓辉 cigna open access drug formulary 2022WebEndoscopic biopsy specimens from primary lesions were collected in 445 of 704 randomized patients in JCOG9912. We measured the mRNA expression of excision repair cross-complementing group 1 (ERCC1), thymidylate synthase, dihydropyrimidine dehydrogenase, and five other genes, then, categorized them into low and high groups relative to the … dhis bummhiWeb3 beds, 2 baths, 2552 sq. ft. house located at 1012 Co Rd 99, Black Hawk, CO 80422 sold for $65,000 on Nov 30, 1983. View sales history, tax history, home value estimates, and … dhis cameroonWebBackground: Since the best chemotherapy regimen for each patient with advanced gastric cancer is uncertain, we aimed to identify molecular prognostic or predictive biomarkers … cigna open access payer idWeb16 feb 2024 · The JCOG9912 trial based on which the JCOG index was constructed was a phase III study of the previous era and did not contain the modern S-1/platinum combinations. Nevertheless, the JCOG index served well as a prognostic indicator among patients who were treated by the state-of-the-art combination regimens that are currently … dhi scoring pdf